Search for: "Lisa Larrimore Ouellette, Daniel Hemel" Results 1 - 20 of 21
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Apr 2020, 9:18 am by willcanderson
Daniel Hemel on the Role of the Private Sector in Battling COVID-19 willcanderson Wed, 04/08/2020 - 11:18 Read more about Daniel Hemel on the Role of the Private Sector in Battling COVID-19 The New York Times Daniel Hemel Lisa Larrimore Ouellette COVID-19 Pharmaceutical Profits and Public Health Are Not Incompatible [read post]
1 Aug 2016, 9:45 am by Paul Caron
Daniel Hemel (Chicago) & Lisa Larrimore Ouellette (Stanford), Knowledge Goods and Nation-States, 101 Minn. [read post]
17 Jul 2018, 3:30 am by Kevin E. Collins
Hemel and Lisa Larrimore Ouellette, Innovation Policy Pluralism, 128 Yale L. [read post]
21 Mar 2017, 1:44 pm
"How 'Price Discrimination' Helps Less-Affluent Countries; The Supreme Court takes up a patent-law case with repercussions far beyond U.S. borders": Law professor Daniel Hemel and Lisa Larrimore Ouellette have this op-ed in today's edition of The Wall Street Journal. [read post]
20 Jul 2015, 3:30 am by Ted Sichelman
Hemel & Lisa Larrimore Ouellette, Beyond the Patents-Prizes Debate, 92 Texas L. [read post]
20 Mar 2015, 5:00 am by Guest Blogger
As Daniel Hemel and I analyzed in Beyond the Patents–Prizes Debate, the state also encourages information production through mechanisms such as tax incentives and direct spending. [read post]
30 Sep 2015, 7:11 am by Jason Rantanen
Guest post by Daniel Hemel, Assistant Professor at the University of Chicago Law School, and Lisa Larrimore Ouellette, Assistant Professor at Stanford Law School. [read post]
29 May 2013, 7:07 am by Lisa Larrimore Ouellette
Hemel & Lisa Larrimore Ouellette (we are of course thrilled to be on this list!) [read post]
Daniel Hemel is an assistant professor at the University of Chicago Law School and Lisa Larrimore Ouellette is an associate professor at Stanford Law School. [read post]
11 Mar 2014, 7:53 am by Guest Blogger
Lisa Larrimore Ouellette is a fellow at the Information Society Project. [read post]
27 Mar 2015, 10:00 am by Guest Blogger
Daniel Hemel and Lisa Ouellette have already situated IP regimes among a variety of other government policy levers designed to affirmatively encourage innovation and market entry, including prizes, grants, and tax incentives [read post]
14 Mar 2014, 12:46 pm by Guest Blogger
  As Lisa Larrimore Ouellette observes in her blog post for this conference, and co-authored paper with Daniel Hemel, delayed and speculative rewards under an ex post incentive regime can deter creative investment. [read post]
5 Mar 2020, 5:15 am by Léon Dijkman
Daniel Hemel and Lisa Larrimore Ouellette suggested that the government award a "large cash prize for any firm that develops a successful coronavirus vaccine". [read post]
12 May 2020, 7:49 am by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceThe antiviral drug remdesivir, developed by California-based biopharmaceutical company Gilead Sciences in collaboration with government scientists, has emerged as the new standard of care for COVID-19 patients. [read post]
12 May 2020, 7:49 am by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceThe antiviral drug remdesivir, developed by California-based biopharmaceutical company Gilead Sciences in collaboration with government scientists, has emerged as the new standard of care for COVID-19 patients. [read post]
9 Mar 2018, 12:54 pm by Camilla Alexandra Hrdy
To give one example, in their recent article, Bayh-Dole Without Borders, Lisa Larrimore Ouellette and Daniel Hemel observe that an under-appreciated feature of making federal funding for research work as an economic policy is ensuring that U.S. companies are able to protect the results of that federally-funded research abroad. [read post]